Evolent Health (EVH) Reports In-Line Q4 EPS; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Evolent Health (EVH) PT Raised to $63 at Cowen
February 23, 2023 1:04 PM ESTCowen analyst Charles Rhyee raised the price target on Evolent Health (NYSE: EVH) to $63.00 (from $59.00) while maintaining a Outperform rating following results.
The analyst commented, "EVH reported adj. EBITDA and revenue above cons. and introduced 2023 guide (adj. EBITDA of $180M-$200M) that was... More
